Compare buffered NAD+ 500mg reports by matching the material and lot, verifying the issuing laboratory, and reading identity, purity, and measured content separately. A strong comparison also distinguishes the supplier’s formulation description from the specific properties measured on the certificate.
This Panda Peptides documentation guide works through an original ILS Laboratories report for NAD+ labeled 500mg. Read the complete two-page certificate y verify it directly with ILS. Report reviewed September 11, 2026.
Start with a traceable report
The example is certificate COA-2026-FS81IM, lot PP2604-032, with an analysis date of September 3, 2026. It identifies NAD+, labeled content 500mg, tested for Panda Peptides. The certificate number and lot make the evidence specific and independently retrievable.
Record the certificate alongside the supplier’s product specification and confirm the lot associated with an order. A 500mg report for one lot should remain clearly identified when other sizes or lots are also offered.
Read all sample results, not just the headline
The certificate reports two samples:
| Sample | HPLC purity | Reported content | Identity |
|---|---|---|---|
| Dedicated V0 | 99.81% | 531.44mg | Confirmed |
| Conformity V1 | 98.57% | 507.03mg | Confirmed |
Both sample rows are marked PASS in the certificate’s HPLC conformity section. Its reported means are 99.19% purity y 519.24mg content. The 99.81% headline is the Dedicated V0 result, not the two-sample mean. Keeping the sample labels visible makes a comparison easier to reproduce.
ILS labels the mg field “Net Peptide Content.” That is the certificate’s field name; NAD+ itself is a nucleotide coenzyme, not a peptide. Preserve the laboratory’s units and method context when recording its result. A measured content result, a purity percentage, and the nominal 500mg label answer different questions.
Separate NAD+ identity from buffer specifications
Panda’s product listing describes buffered NAD+ 500mg. The example certificate reports NAD+ identity as “Confirmed” by HPLC-RTM. It does not list a measured pH or a quantitative buffer-composition result.
For a laboratory comparing formulations, keep a separate specification field for the stated buffer and any required pH conditions. Look for a named measurement and result if those properties matter to the purchasing specification. NAD+ identity, buffer composition, and pH are distinct attributes; they should not be treated as interchangeable evidence.
Compare additional panels on their own terms
The full ILS document also includes elemental-impurity, PCR sterility, endotoxin, and fentanyl-screen sections. Read each panel’s stated method, units, specification, and result. For example, preserve “PCR” when recording the microbial test; do not relabel it as a different compendial test.
Use your laboratory’s documented acceptance criteria to decide which panels matter. A broad panel is useful because it supplies separate measurements, not because one PASS label makes all analytical methods equivalent. These results relate to the samples tested.
A reusable comparison checklist
- Material: NAD+ form, nominal amount, formulation specification, and lot.
- Source: independent laboratory, original certificate, certificate number, and verification date.
- Results: identity method, HPLC purity, content with units, and every tested sample.
- Formulation: separately documented buffer or pH measurements where required.
- Additional testing: the exact panels and methods relevant to the purchasing specification.
- Traceability: the report-to-order match and a retained copy of the original report.
Review Panda’s NAD+ evidence
Compare the sample-level results directly with the original ILS certificate, then visit Buffered NAD+ 500mg for product details and available documentation. Our testing-laboratory directory explains the independent report sources. For a peptide example of the same reading method, see How to Read a Tesamorelin 10mg COA.
For laboratory research procurement. This guide interprets analytical documentation; it does not provide preparation or administration instructions.